Olympus Corp

OLY1

Company Profile

  • Business description

    Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2025, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.

  • Contact

    2951 Ishikawacho
    Hachioji192-8507
    JPN

    T: +81 333402111

    https://www.olympus.co.jp

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 March 2026

    Employees

    29,996

Stocks News & Analysis

stocks

Ask the analyst: Can this genius product create the next ASX software king?

SiteMinder’s newly released product for hotel owners and travel agents could widen its moat and see revenue accelerate further.
stocks

Impact of ANZ’s huge fine

Working to prevent repeated failures could also improve competitiveness.
stocks

Acquisition a sign of weakness for overvalued ASX share

Acquisition unlikely to improve prospects in the US and detracts from other opportunities.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,094.9027.60-0.30%
CAC 407,813.744.48-0.06%
DAX 4023,373.7044.460.19%
Dow JONES (US)45,757.90125.55-0.27%
FTSE 1009,216.5520.890.23%
HKSE26,908.39469.881.78%
NASDAQ22,333.9614.79-0.07%
Nikkei 22544,790.38111.89-0.25%
NZX 50 Index13,228.386.51-0.05%
S&P 5006,606.768.52-0.13%
S&P/ASX 2008,818.5030.00-0.34%
SSE Composite Index3,876.3414.480.37%

Market Movers